GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 872 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 76-100 of 137 matching filings.

Per page
25
Current page
4
8-K File 000-08092

GTBP 8-K ITEM 3.02

Filing date
19 Apr 2019
Reporting date
19 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

GTBP 8-K FILING OF CERTIFICATE OF DESIGNATION

Filing date
05 Apr 2019
Reporting date
04 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

GTBP 8-K RESIGNATION OF DIRECTORS AND APPOINTMENT OF CFO

Filing date
22 Mar 2019
Reporting date
20 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

GTBP 8-K ITEM 5.02

Filing date
21 Mar 2019
Reporting date
15 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
06 Feb 2019
Reporting date
04 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
15 Nov 2018
Reporting date
15 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
01 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
16 Oct 2018
Reporting date
11 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
12 Oct 2018
Reporting date
09 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

FORM 8-K

Filing date
28 Sep 2018
Reporting date
24 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
07 Sep 2018
Reporting date
07 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
03 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
05 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
14 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
27 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-08092

CURRENT REPORT

Filing date
15 Mar 2018
Reporting date
19 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
21 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
23 Jan 2018
Reporting date
22 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
16 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

PRIMARY DOCUMENT

Filing date
16 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
12 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

GT BIOPHARMA 8-K

Filing date
25 Jul 2017
Reporting date
17 Jul 2017
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .